186 related articles for article (PubMed ID: 29639)
1. Structure-binding-activity analysis of beta-adrenergic amines--II. Binding to the beta receptor and inhibition of adenylate cyclase.
Bilezikian JP; Dornfeld AM; Gammon DE
Biochem Pharmacol; 1978 May; 27(10):1455-61. PubMed ID: 29639
[No Abstract] [Full Text] [Related]
2. Structure-binding-activity analysis of beta-adrenergic amines--I. Binding to the beta receptor and activation of adenylate cyclase.
Bilezikian JP; Dornfeld AM; Gammon DE
Biochem Pharmacol; 1978 May; 27(10):1445-54. PubMed ID: 29638
[No Abstract] [Full Text] [Related]
3. Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor.
Weiland GA; Minneman KP; Molinoff PB
Nature; 1979 Sep; 281(5727):114-7. PubMed ID: 38405
[TBL] [Abstract][Full Text] [Related]
4. Agonist- induced transconformation of beta-adrenergic receptors, and adenylate cyclase activation [proceedings].
Vauquelin G; Bottari S; Strosberg AD
Arch Int Physiol Biochim; 1979 Oct; 87(4):859-60. PubMed ID: 93949
[No Abstract] [Full Text] [Related]
5. Interactions of agonists and antagonists with beta-adrenergic receptors.
Molinoff PB; Weiland GA; Heidenreich KA; Pittman RN; Minneman KP
Adv Cyclic Nucleotide Res; 1981; 14():51-67. PubMed ID: 6116391
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the influence of N-isopropyl and N-tert butyl substituents on the affinity of ligands for sinoatrial beta-adrenoceptors in rat atria and beta-adrenoceptors coupled to the adenylyl cyclase in kitten ventricle.
Kaumann AJ; Morris TH; Birnbaumer L
Naunyn Schmiedebergs Arch Pharmacol; 1979 May; 307(1):1-8. PubMed ID: 39258
[No Abstract] [Full Text] [Related]
7. A new method for measuring binding of labeled ligands to membrane receptors.
Chantot JF; Saul AJ
Anal Biochem; 1978 Jan; 84(1):256-62. PubMed ID: 24362
[No Abstract] [Full Text] [Related]
8. Structure-activity study of beta-adrenergic agents using the SIMCA method of pattern recognition.
Dunn WJ; Wold S
J Med Chem; 1978 Sep; 21(9):922-30. PubMed ID: 31486
[TBL] [Abstract][Full Text] [Related]
9. The beta-adrenergic receptor of turkey erythrocyte membranes: conformational modification by beta-adrenergic agonists.
Bottari S; Vauquelin G; Durieu O; Klutchko C; Strosberg AD
Biochem Biophys Res Commun; 1979 Feb; 86(4):1311-8. PubMed ID: 35165
[No Abstract] [Full Text] [Related]
10. Comparison of pharmacological and binding assays for ten beta-adrenoceptor blocking agents and two beta-adrenoceptor agonists.
Bieth N; Rouot B; Schwartz J; Velly J
Br J Pharmacol; 1980 Mar; 68(3):563-9. PubMed ID: 6132636
[TBL] [Abstract][Full Text] [Related]
11. Identity of [3H]dihydroalprenolol binding sites and beta-2 adrenergic receptors coupled with adenylate cyclase in guinea-pig skeletal muscle sarcolemma: general properties and structure-activity relationships.
Wei JW; Sulakhe PV
J Pharmacol Exp Ther; 1980 Jul; 214(1):186-96. PubMed ID: 6104715
[No Abstract] [Full Text] [Related]
12. Direct determination of ligand interactions with beta-adrenergic receptors on intact turkey erythrocytes: correlation of binding with biological activity.
Brown EM; Gardner JD; Aurbach GD
Endocrinology; 1976 Nov; 99(5):1370-6. PubMed ID: 11095
[TBL] [Abstract][Full Text] [Related]
13. Comparison of specificity of agonist and antagonist radioligand binding to beta adrenergic receptors.
Lefkowitz RJ; Hamp M
Nature; 1977 Aug; 268(5619):453-4. PubMed ID: 19707
[No Abstract] [Full Text] [Related]
14. Selective alteration in high affinity agonist binding: a mechanism of beta-adrenergic receptor desensitization.
Wessels MR; Mullikin D; Lefkowitz RJ
Mol Pharmacol; 1979 Jul; 16(1):10-20. PubMed ID: 39240
[No Abstract] [Full Text] [Related]
15. Binding of agonists and antagonists to beta-adrenergic receptor.
Miklavc A; Kocjan D; Hadzi D; Mavri J; Koller J
Prog Clin Biol Res; 1989; 291():275-80. PubMed ID: 2567011
[No Abstract] [Full Text] [Related]
16. Effects of full and partial beta-adrenergic agonists and antagonists on human lung adenylate cyclase.
Delhaye M; Taton G; Camus JC; Chatelain P; Robberecht P; Waelbroeck M; Christophe J
Biochem Pharmacol; 1983 Jun; 32(12):1831-5. PubMed ID: 6136280
[TBL] [Abstract][Full Text] [Related]
17. Characterization of alpha- and beta-adrenergic receptors linked to human platelet adenylate cyclase.
Jakobs KH; Saur W; Schultz G
Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 302(3):285-91. PubMed ID: 26887
[No Abstract] [Full Text] [Related]
18. Mobility, localization, and heterogeneity of beta-adrenergic receptors.
Hekman M; Schiltz E; Henis YI; Elson EL; Helmreich EJ
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():47-60. PubMed ID: 6145328
[No Abstract] [Full Text] [Related]
19. Antagonist dissociation constants and relative agonist efficacies for compounds interacting with beta-1 and beta-2 adrenergic receptors in the rat jugular vein.
Cohen ML; Ruffolo RR; Wiley KS
J Pharmacol Exp Ther; 1980 Nov; 215(2):325-31. PubMed ID: 6108357
[No Abstract] [Full Text] [Related]
20. Structure-activity relationships of beta-adrenergic receptor-coupled adenylate cyclase: implications of a redox mechanism for the action of agonists at beta-adrenergic receptors.
Wong A; Hwang SM; Cheng HY; Crooke ST
Mol Pharmacol; 1987 Apr; 31(4):368-76. PubMed ID: 2883567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
